Outcome of Board Meeting

Astec LifeSciences Ltd. ASTEC Date: 26th October, 2026 To, To, BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra – Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai-400 051 Ref.: BSE Scrip Code No. “533138” Ref.: “ASTEC” Debt Segment NSE: NCD-ASTEC-ISIN: INE563J08023 Sub.: Outcome of the Board Meeting Pursuant to Regulations 30, 33 and 52(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today, i.e., on Monday, 26th October, 2026 (which commenced at 3.30 p.m. and concluded at . p.m.), inter alia, has approved / noted the following: (a)43A9pproval of the Unaudited Financial Results (Standalone & Consolidated) for the Quarter and Half Year ended 30th September, 2026: Upon recommendation of the Audit Committee, the Board of Directors has approved the Unaudited Financial Results (Standalone & Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2026, along with the Cash Flow Statement for the said period and the Statement of Assets and Liabilities as on 30th September, 2026 (enclosed herewith). (b) Noting of the Limited Review Reports of the Statutory Auditors for the Quarter and Half Year ended 30th September, 2026: The Board of Directors took note of the Limited Review Reports of the Statutory Auditors on the Unaudited Financial Results (Standalone & Consolidated) for the Quarter and Half Year ended 30th September, 2026 (enclosed herewith). The Limited Review Reports of the Statutory Auditors are with unmodified opinion with respect to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Half Year ended 30th September, 2026. Please take the above information on your records. Thanking you, Yours sincerely, For Astec LifeSciences Limited Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167) Encl.: As above Regd Office "Godret One", 3• Floor, Pro1st-enagar. Eastern Express Highway, ViklYolt (East}, Mumba • 400079, Maha'asltra, lrdoa TelephoneNo 022-25188010 Fax No 022-22618289 Ema~ Id asteonlo@godre13stec com Website wwwgodreiasteccom CIN L99999MHl994PLC076236 Astec LifeSciences Limited Corporate Identity Number : L99999MH1994PLC076236 Registered Office: Godrej One, 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikhroli (East), Mumbai-400079, Maharashtra Website: www.godrejastec.com, Tel no.: 022-2519 5768, Fax no.: 022-2261 8289, Email Id: asteclnvestors@godrejastec.com STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF-YEAR ENDED SEPTEMBER 30, 2026 ~sin lakh) Standalone Consolidated Year to date figure for the Year to date figure for the Quarter Ended Year Ended Quarter Ended Year Ended Period Ended Period Ended Particulars 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) INCOME 7,202.01 8,356.43 7,372.06 15,558.44 16,480.27 44,814.56 Revenue From Operations 7,202.01 8,356.43 7,372.06 15,558.44 16,480.27 44,814.56 59.72 70.85 109.44 130.57 158.10 498.87 Other Income 61.63 72.74 111.56 134.37 162.21 507.09 7,261.73 8,427.28 7 481.50 15,689.01 16,638.37 45.313.43 TOTAL INCOME 7 263.64 8,429.17 7,483.62 15,692.81 16,642.48 45,321.65 EXPENSES 5,627.83 7,632.28 5,811.92 13,260.11 11,752.54 27,045.00 Cost of materials consumed 5,627.83 7,632.28 5,811.92 13,260.11 11,752.54 27,045.01 Changes in inventories of finished goods and Work-in- (404.96) (3,370.38) (1,683.66) (3,775.34) (1,235.89) 2,796.44 (404.96) (3,370.38) (1,683.66) (3,775.34) (1,235.89) 2,796.44 progress 1,510.78 1,599.96 1,562.26 3,110.74 3,080.67 6,290.81 Employee benefits expense 1,510.78 1,599.96 1,562.26 3,110.74 3,080.67 6,290.81 707.86 773.99 840.86 1,481.85 1,945.76 3,456.76 Finance costs 707.04 773.18 839.74 1,480.22 1,944.12 3,452.89 1,120.02 1,108.62 1,045.73 2,228.64 2,196.75 4,499.34 Depreciation and amortisation expenses 1,118.16 1,106.77 1,043.88 2,224.93 2,193.29 4,492.18 2,447.16 2,560.73 2,349.48 5,007.89 4,649.27 9,132.84 Other expenses 2,447.57 2,561.18 2,350.22 5,008.75 4,650.24 9,134.90 11,008.69 10,305.20 9,926.59 21,313.89 22,389.10 53,221.19 TOTAL EXPENSES 11,006.42 10,302.99 9,924.36 21,309.41 22,384.97 53,212.23 (3,746.96) (1877.92) (2 445.09) (5 624.88) (5,750.73) (7,907.76) LOSS BEFORE EXCEPTIONAL ITEMS & TAX (3,742.78) (1,873.82) (2,440.74) (5,616.60) (5,742.49) (7,890.58) - - - - 209.43 Exceptional items (Refer Note 3) - - - - 209.43 (3,746.96) (1,877.92) (2,445.09) (5,624.88) (5,750.73) (8,117.19) LOSS BEFORE TAX (3,742.78) (1,873.82) (2,440.74) (5,616.60) (5,742.49) (8,100.01) (4.08) {4.08) - (8.16) - (16.31) Tax expense: (3.07) (3.09) 0.96 (6.16) 1.90 (12.39) - - - - - I . Current tax 1.00 0.98 0.94 1.98 2.00 4.00 (4.08) (4.08) . (8.16) . (16.31) 2. Deferred tax expense/ (income) (4.07) (4.07) 0.02 (8.14) (0.10) (16.39) (3 742.88) (1,873.84) (2,445.09) (5,616.72) (5 750.73) (8,100.88) LOSS FOR THE PERIOD (3,739.71) (1,870.73) (2 441.70) (5,610.44) (5 744.39) (8,087.62) (Rs in lakh) Standalone Consolidated Year to date figure for the Year to date figure for the Quarter Ended Year Ended Quarter Ended Year Ended Period Ended Period Ended Particulars 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) OTHER COMPREHENSIVE INCOME 16.20 16.20 5.64 32.40 11.28 64.80 (A) (i) Items that will not be reclassified to profit or loss 16.20 16.20 5.64 32.40 11.28 64.80 (4.08) (4.08) - (8.16) - (16.31) (ii) Income tax related to Items that will not be (4.08) (4.08) - (8.16) - (16.31) reclassified to profit or loss - - - - - (B) (i) Items that will be reclassified to profit or loss (0.50) (0.77) 0.35 (1.27) 0.06 (2.32) (ii) Income tax related to items that will be reclassified - - - - - to vrofit or loss - - - - TOT AL OTHER COMPREHENSIVE INCOME FOR 12.12 12.12 5.64 24.24 11.28 48.49 THE PERIOD, NET OF INCOME TAX 11.62 11.35 5.99 22.97 11.34 46.17 TOTAL COMPREHENSIVE LOSS FOR THE PERIOD (3,730.76) (1,861.72) (2,439.45) (5,592.48) (5,739.45) (8,052.39) (3 728.09) Cl 859.38) (2,435.71) (5,587.47) (5,733.05) (8,041.45) Loss for the period attributable to: a) Owners of the Company (3,740.73) (1,871.74) (2,442.70) (5,612.47) (5,746.48) (8,091.75) b) Non Controlling Interest 1.02 1.01 1.00 2.03 2.09 4.13 Other Comprehensive Income attributable to: a) Owners of the Company 11.62 11.35 5.99 22.97 11.34 46.17 b) Non Controlling Interest - - - - - - Total Comprehensive Loss attributable to: a) Owners of the Company (3,729.11) (1,860.39) (2,436.71) (5,589.50) (5,735.14) (8,045.58) b) Non Controlling Interest 1.02 1.01 1.00 2.03 2.09 4.13 Paid-up Equity share capital (Face Value Rs. 10 per 2,228.28 2,228.28 2,228.17 2,228.28 2,228.17 2,228.22 share) 2,228.28 2,228.28 2,228.17 2,228.28 2,228.17 2,228.22 36,758.42 Other Equity 36,832.36 Earnings per equity share of Rs. 10 each (non-annualized) (16.80) (8.41) (11.39) (25.21) (27.99) (37.83) Basic (Rs.) (16.79) (8.40) (11.35) (25.19) (27.97) (37.79) (16.80) (8.41) (11.39) (25.21) (27.99) (37.83) Diluted (Rs.) (16.79) (8.40) (11.34) (25.19) (27.97) (37.79) Astec LifeSciences Limited Corporate Identity Number: L99999MH1994PLC076236 Registered Office: Godrej One, 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikhroli (East), Mumbai-400079, Maharashtra Website: www.godrejastec.com, Tel no.: 022-2519 5768, -Fax no;: 022°2261 8289, Email id: astecinvestors@godrejastec.com Statement of Assets and Liabilities (Rs. in l [Showing first 8,000 characters — download PDF for full document]